Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146042
Status:
COMPLETED
Last Update Posted:
2012-10-05
First Post:
2005-09-01
Brief Title:
UMCC 9901 Phase II Study of Tailored-Dose Docetaxel Trastuzumab in Her-2 Positive Metastatic Breast Cancer
Sponsor:
Organization:
University of Michigan Rogel Cancer Center